Niagen Bioscience, Inc. (NAGE)

Market Cap	791.21M
Revenue (ttm)	116.30M
Net Income (ttm)	17.73M
Shares Out	79.92M
EPS (ttm)	0.22
PE Ratio	46.00
Forward PE	66.00
Dividend	n/a
Ex-Dividend Date	n/a

Volume	768,705
Open	9.80
Previous Close	9.82
Day's Range	9.65 - 10.06
52-Week Range	3.10 - 14.69
Beta	2.12
Analysts	Strong Buy
Price Target	17.00 (+71.72%)
Earnings Date	Oct 30, 2025

About NAGE

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+) test kits to healthcare practitioners; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and ph...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1999
• Employees: 104
• Stock Exchange: NASDAQ
• Ticker Symbol: NAGE
• Website: https://www.niagenbioscience.com

Analyst Summary

According to 3 analysts, the average rating for NAGE stock is "Strong Buy." The 12-month stock price target is $17.0, which is an increase of 71.72% from the latest price.

Price Target

$17.0

(71.72% upside)

Analyst Consensus: Strong Buy